| Quality of life, symptom experience and distress of lung cancer patients undergoing chemotherapy S Akin, G Can, A Aydiner, K Ozdilli, Z Durna European journal of oncology nursing 14 (5), 400-409, 2010 | 256 | 2010 |
| Multiple primary neoplasms at a single institution: differences between synchronous and metachronous neoplasms A Aydiner, A Karadeniz, K Uygun, S Tas, F Tas, R Disci, E Topuz American journal of clinical oncology 23 (4), 364-370, 2000 | 212 | 2000 |
| The quality of life and self-efficacy of Turkish breast cancer patients undergoing chemotherapy S Akin, G Can, Z Durna, A Aydiner European journal of oncology nursing 12 (5), 449-456, 2008 | 203 | 2008 |
| Anemia in oncology practice: relation to diseases and their therapies F Tas, Y Eralp, M Basaran, B Sakar, S Alici, A Argon, G Bulutlar, ... American journal of clinical oncology 25 (4), 371-379, 2002 | 186 | 2002 |
| Assessment of fatigue in and care needs of Turkish women with breast cancer G Can, Z Durna, A Aydiner Cancer nursing 27 (2), 153-161, 2004 | 144 | 2004 |
| Meme kanseri E Topuz Nobel, 2003 | 126* | 2003 |
| Prognostic factors in pancreatic carcinoma: serum LDH levels predict survival in metastatic disease F Tas, F Aykan, S Alici, E Kaytan, A Aydiner, E Topuz American journal of clinical oncology 24 (6), 547-550, 2001 | 124 | 2001 |
| Quality of life and complementary and alternative medicine use among cancer patients in Turkey G Can, O Erol, A Aydiner, E Topuz European Journal of Oncology Nursing 13 (4), 287-294, 2009 | 116 | 2009 |
| A comparison of men and women's experiences of chemotherapy-induced alopecia G Can, M Demir, O Erol, A Aydiner European Journal of Oncology Nursing 17 (3), 255-260, 2013 | 95 | 2013 |
| MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer Y Eralp, D Derin, Y Ozluk, E Yavuz, N Guney, P Saip, M Muslumanoglu, ... Annals of oncology 19 (4), 669-674, 2008 | 89 | 2008 |
| Granulosa cell tumor of the ovary: retrospective analysis of 45 cases K Uygun, A Aydiner, P Saip, M Basaran, F Tas, Z Kocak, M Dincer, ... American journal of clinical oncology 26 (5), 517-521, 2003 | 83 | 2003 |
| Serum lactate dehydrogenase levels at presentation predict outcome of patients with limited-stage small-cell lung cancer F Tas, A Aydiner, C Demir, E Topuz American journal of clinical oncology 24 (4), 376-378, 2001 | 80 | 2001 |
| Clinical parameters and treatment results in recurrent granulosa cell tumor of the ovary K Uygun, A Aydiner, P Saip, Z Kocak, M Basaran, M Dincer, E Topuz Gynecologic oncology 88 (3), 400-403, 2003 | 74 | 2003 |
| Metaplastic breast carcinoma versus triple-negative breast cancer: survival and response to treatment A Aydiner, F Sen, M Tambas, R Ciftci, Y Eralp, P Saip, H Karanlik, ... Medicine 94 (52), e2341, 2015 | 69 | 2015 |
| Meta-analysis of breast cancer outcome and toxicity in adjuvant trials of aromatase inhibitors in postmenopausal women A Aydiner The Breast 22 (2), 121-129, 2013 | 68 | 2013 |
| The efficiency of the acupressure in prevention of the chemotherapy-induced nausea and vomiting A Genç, G Can, A Aydiner Supportive Care in Cancer 21, 253-261, 2013 | 66 | 2013 |
| Evaluation of the effect of care given by nursing students on oncology patients’ satisfaction G Can, S Akin, A Aydiner, K Ozdilli, Z Durna European journal of oncology nursing 12 (4), 387-392, 2008 | 61 | 2008 |
| Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer. F Tas, A Aydiner, E Topuz, V Yasasever, A Karadeniz, P Saip Journal of experimental & clinical cancer research: CR 19 (4), 477-481, 2000 | 61 | 2000 |
| Autophagy and nuclear changes in FM3A breast tumor cells after epirubicin, medroxyprogesterone and tamoxifen treatment in vitro A Bilir, MA Altinoz, M Erkan, V Ozmen, A Aydiner Pathobiology 69 (3), 120-126, 2002 | 56 | 2002 |
| Meme kanseri tanı tedavi takip A Aydıner, E Topuz İstanbul: Nobel Tıp Kitabevleri, 2007 | 53 | 2007 |
